|
Reasons for Prescribing Sertindole Treatment |
||
| Number of patients (%) |
||
|
|
||
| Reasons |
"Before" subgroup (n = 1,039)* |
"After" subgroup (n = 393)** |
|
|
||
| Lack of efficacy of previous treatment |
498 (49.0%) |
222 (57.2%) |
| Adverse event under previous treatment |
259 (25.5%) |
73 (18.8%) |
| Patient desire to continue |
146 (14.4%) |
41 (10.6%) |
| Non compliance to previous treatment |
74 (7.2%) |
27 (7.0%) |
| Other reasons |
40 (3.9%) |
25 (6.4%) |
|
|
||
| Total |
1,017 (100.0%) |
388 (100.0%) |
|
* This group consisted of patients who started taking sertindole before the market suspension and who continued to take it during the suspension; information was missing for 22 patients ** This group consisted of patients who started taking sertindole during the market suspension; information was missing for 5 patients | ||
Lançon et al. BMC Psychiatry 2008 8:57 doi:10.1186/1471-244X-8-57 |
||